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CLINICAL ARTICLES

Human Granulocytic Ehrlichiosis in Europe: Clinical and Laboratory Findings
for Four Patients from Slovenia
Stanka Lotric-Furlan,Miroslav Petrovec,
Tatjana Avsic Zupanc, William L. Nicholson,
John W. Sumner, James E. Childs, and Franc Strle

From the Departmentof InfectiousDiseases, UniversityMedical Centre,
and the Instituteof Microbiology and Immunology,Medical Faculty,
Universityof Ljubljana,Ljubljana,Slovenia; and the Viraland
RickettsialZoonoses Branch, Centersfor Disease Control and
Prevention,Atlanta, Georgia, USA

Febrile illnesses following a tick bite in patients from Slovenia were evaluated for an ehrlichial
etiology. A case of acute human granulocyticehrlichiosis(HGE) was confirmedby seroconversion
to the HGE agent or molecularidentificationof ehrlichialorganisms.Acute infectionwith the HGE
agent was confirmedin four patients. None of the patients had detectableantibodiesto the HGE
agent at their first visit, but polymerasechain reaction analysis was positive for three patients. All
four patients subsequentlyseroconvertedto the HGE agent as shown by high titers of antibody.
Clinical features and laboratoryfindings were similar to those in reports from the United States,
althoughthe disease coursewas relativelymild in the Sloveniancases. All patientsrecoveredrapidly
and without sequelae,although only two receivedantibiotictherapy(of whom only one was treated
with doxycycline).HGE is an emergingtick-bornedisease in the United States and should now be
included in the differentialdiagnosis of febrile illnesses occurringafter a tick bite in Europe.

Humangranulocyticehrlichiosis(HGE)is a tick-bomezoonosis recentlydescribedin the UnitedStatesthatis causedby
anEhrlichiaspeciesclosely relatedor conspecificto the known
animalpathogensEhrlichiaphagocytophilaandEhrlichiaequi
[1]. In the UnitedStates,white-taileddeerandsmallmammals
may serve as primaryreservoirsof the HGE agent, and the
tick Ixodesscapularishas been shownto be a competentvector [2-5].
The presenceof antibodiesto Ehrlichiaantigenshas been
documentedin serafromindividualsfromSwitzerland[6], the
UnitedKingdom[7], Italy [8], Norway [9], and Sweden [10].
However,clinical descriptionof acute HGE in Europeis limited to a single case documentedin June1996 in Slovenia[11].
Slovenia is a region in which severaltick-bomediseases are
endemic.The annualincidenceof tick-bomeencephalitisand
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Lyme borreliosis,both transmittedby Ixodes ricinusticks, in
Slovenia is among the highest in Europe[12, 13]. However,
each summer,numerouspatientsdevelopa febrileillness after
a tick bite for which an etiology has neverbeen established.
The aim of this prospectivestudywas to determineif infection with an Ehrlichiaspecies was associatedwith febrileillnesses occurringaftera tick bite. Hereinwe reportthe clinical
presentationand laboratoryconfirmationof the firstfour consecutivecases of HGE occurringoutsideof the UnitedStates.

Patients and Methods
A studyto assess the potentialehrlichialetiology of febrile
illnesses after a tick bite was conductedat the Department
of InfectiousDiseases, UniversityMedicalCentre,Ljubljana,
Slovenia,betweenMarch 1995 and December1996. Patients
with a febrileillnesswerereferredfor evaluationto ourinstitution by primarycare physicians;only patientswith a history
of a tick bite in the preceding6 weeks were eligible for the
study.Patientswere examinedat the time of theiracuteillness
and 14 days, 6-8 weeks, 6 months,and 12 monthslater.Suspectedacutecases of HGEwere confirmedby seroconversion
with a minimumfourfoldrise in titerof antibodyto HGEagent
antigenor by PCRanalysiswith subsequentsequencingof the
amplicons.One patient (no. 1, table 1) has been described
previously[11].
At the firstvisit, blood sampleswereobtainedfor determinationof a completebloodcell countandserumchemistryprofile,
includingconcentrationsof serumaspartateaminotransferase,

This article is a U.S. government work, and is not subject to copyright in the United States.

Table 1.

Demographic characteristics and clinical presentation of four patients with human granulocytic ehrlichiosis in Slovenia.

Patient Age
no.
(y)/sex
1
2
3
4
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70/F
59/F
43/M
55/F

Incubation
period* Temperaturet
Chills Headache Vertigo Nausea Malaise Myalgia Arthralgia
(d)
(?C)
12
21
7
30

40
41
40
39.3

+
+
-

+
+
+
+

-

+
+

+

+

+

+
+
+
+

+
+
+
+

+
+
+
+

Other

Antibiotic
treatment

None
Doxycycline+
Dry cough Azithromycin?
Vomiting None

Vomiting
-

Duration
of fever
(d)
5
4
9
7

NOTE. + = present;- = absent.
* Time from tick bite to the onset of illness.
tMaximum body temperaturerecorded.
Dosage, 100 mg b.i.d. for 12 days;treatmentwas instituted2 days afterspontaneousdefervescence.
?Dosage, 250 mg b.i.d. on the firstday, followed by 250 mg q.d. for the following4 days;treatmentwas institutedon the secondday of illness by a primary
physicianbecauseof suspicionof atypicalpneumonia.

alanine aminotransferase,
serum bilirubin,alkalinephosphatase, lactate dehydrogenase,creatinephosphokinase,and Creactiveprotein.Clinicallaboratoryprocedureswere repeated
at sequentialexaminations.Giemsa-stainedperipheralblood
smearswere examinedby use of lightmicroscopyfor the presence of ehrlichialmorulaewithin WBCs.
Acute- and convalescent-phaseserum sampleswere tested
by use of an indirectimmunofluorescence
assay (IFA) for the
of
antibodies
to
the
HGE
presence specific
agent(with use of
the USG3 strain,whichwas propagatedin HL60promyelocyte
cells) [14]. Thistest uses a polyvalentconjugate(goatantibody
to humanIgG with heavy and light chains) and will detect
humanIgG andany otherimmunoglobulinclasses with similar
light chains.A similarIFA is also conductedwith use of Ehrlichia chaffeensisantigen (MRL Diagnostics,Cypress,CA).
IgM and IgG antibodiesto othertick-bore agents were also
assessed by IFA for Borrelia burgdorferisensu lato (whole
cells of a local isolateofBorrelia afzelii)andRickettsiaconorii
(bioMerieux,Lyon,France)or by use of an ELISAkit (Immunozyme, FSME, ImmunoAG, Vienna) for the presence of
antibodyto tick-borneencephalitisvirus.
DNA was extractedfromWBCs in the buffy coat and used
as a templatefor PCR reactionswith 16S rRNAgene primers
GE9f and GElOr,specificto the E. phagocytophilagenogroup
(E.phagocytophila,E. equi,andthe HGEagent)[1], andprimersHE1andHE3,specificto E. chaffeensis[15]. Thesesamples
were also tested with a nested PCR method[16] designedto
detect E. chaffeensisand membersof the E. phagocytophila
genogroupby amplificationof partof the groESLheat shock
operon. PrimersHS1 and HS6 were used in primaryPCR
reactions.Samples(1 /1L)of productsof the primaryreactions
wereused as a templatefor nestedreactionswithprimersHS43
andHS45 [16]. PrimersHS43 andHS45 spana 442-bpregion
thatincludesthe intergenicspacerbetweenthegroESgene and
the groEL gene and a 392-bp region of the amino coding
terminusof the groEL gene. PrimersHS43 and HS45 were
used in the initial PCR testingbecause they also amplifythe
homologousregion of the E. chaffeensisgroESLoperon.

A variableregionof the EhrlichiagroELgene was amplified
in additionalnested reactionswith use of primersHS43 or
HSVF (5'-CAATAAGCTCCGTGGTGGCCTTC)
pairedwith
HSVR
The
primer
(5'-CTCAACAGCAGCTCTAGTAGC).
nucleotidesequencesfor primersHSVF and HSVR were not
reportedpreviously,but the cycling parameterswere as previously described [16]. Primers HSVF and HSVR span a
395-bpregionof the groELgene thatincludesnucleotides812
through1,206 when adenineof the putativegroELtranslation
initiationcodonis designatednucleotide1. PCRproductswere
separatedand detectedby electrophoresisin agarosegels containingethidiumbromide.Amplifiedbandsof DNA were excised and purifiedfrom the gel for sequencing.PurifiedPCR
productswere sequencedby using the PrismReady Reaction
dideoxycycle sequencingkit (AppliedBiosystems,FosterCity,
CA). Both strandsof each productwere sequencedwith use
of sets of primersfrom conservedregions [16].
Results
The diagnosisof acuteHGEwas confirmedin fourpatients
(table 1). Threepatientswere female,andthe meanage of the
patientswas 57 years.All the patientspresentedbetweenJune
and August 1996 and recalleda tick bite 7 to 30 days before
the onset of their symptoms.
Twopatientsrequiredhospitalization,
whiletwo weretreated
as outpatients.In all patients,the highest temperaturewas
339.3?C.Feverabatedspontaneouslyin all patients,including
two who had receivedno antibiotictherapyand one who was
treatedwith doxycycline2 days afterdefervescence.Withthe
exceptionof fever, clinical examinationsrevealedfew significant abnormalities:one patientpresentedwith conjunctivitis
and mildly enlargedcervicallymphnodes, and one had pneumoniathatwas demonstrated
Thispatient(no.
radiographically.
table
had
clinical
characteristicsof atypicalpneumonia
3,
2)
and was seronegativeat all times for Coxiellaburnetii,Chlamydiapneumoniae, Chlamydiapsittaci, and Mycoplasma pneu-

moniae.Rashwas not presentin any of the patients.In all four
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Table 2. Summary of initial principal laboratory data and physical examination findings for patients with acute human granulocytic ehrlichiosis
in Slovenia.
Laboratoryfinding
Physicalexaminationfinding
Patient
no.

Day
of
illness

Temperature
(?C)

1

3

39.5

2
3
4

6
5
7

39.8
39.0
39.3

Other
Conjunctivitis,cervical
lymphadenopathy
-t
-

ESR
(mm/h)

WBC
count*
(x 109/L)

Thrombocyte
countt
(X 109/L)

CRP
level
(mg/L)

AST
level
(U/L)

ALT
level
(U/L)

LDH
level
(U/L)

CPK
level
(U/L)

11

6.0

118

58

30

14

390

240

24
54
11

3.4
10.9
1.9

37
219
60

179
83
12

38
100
16

37
107
13

372
214
209

60
120
102

NOTE. ALT = alanineaminotransferase
(normalvalue, 0-42 U/L); AST = aspartateaminotransferase
(0-36 U/L); CPK = creatinephosphokinase(42124 U/L); CRP = C-reactiveprotein(<5 mg/L); ESR = erythrocytesedimentationrate (<20 mm/h);LDH = lactate dehydrogenase(140-290 U/L); - =
absent.
* Normalvalue, 4.0-10.0 X 109/L.
t Normalvalue, 150-350 X 109/L.
I Duringlaterexaminations,
pneumoniawas demonstrated
radiographically.

patients, the clinical course was favorable:none of them
died, and no long-termconsequenceswere found during a
follow-upperiodof 1 year.
Themostcommonlaboratoryabnormalities
werean elevated
concentrationof serumC-reactiveprotein(4 patients),thrombocytopenia(3), elevatedliver enzyme levels (3), leukopenia
(2), and an elevatederythrocytesedimentationrate (2) (table
2). Lymphopeniawas found in only one patient.This patient
also had granulocytosiswith a markedleft shift. None of the

patientshad elevatedserumcreatinineandblood ureanitrogen
levels or anemia(datanot shown).
Despite intensive examination,intracytoplasmicmorulae
were not seen in any leukocyteson the blood smears.
Acute infectionwith the HGEagentwas indicatedby seroconversionfroma negativetiterof antibody(< 1/64) to a high
titer of polyvalentantibodyto HGE agent antigenin all four
patients(table3). In addition,patient2 developeda high titer
of antibodyto E. chaffeensisantigen,andpatient1 hada stand-

Table 3. Results of PCR analysis and titers of antibody to different tick-transmitted agents for four Slovenian patients tested at different
times after the onset of HGE.
PCR analysis*
Patientno.,
day from onset
of the illness

rRNA
gene

groESL
operon

IFA for
antibodyto
HGE agent

+
-

+
NT
NT

256t
512

IFA for IgG to
Ehrlichiachaffeensis

IgM/IgG
to
TBEV

IgM/IgGto Borrelia
burgdorferi

IgG to Rickettsia
conorii

-/
NT
/-

-/128
NT
128/256

NT

1

3
14
46

-

128
128
128

2
11

+

+

-

24
67

-

NT
NT

1,024
2,048

>4,096
1,024

NT
-/+

NT
-/-

NT

20
54

-

NT
NT

256
256

-

NT
-/-

NT
-/-

NT

7
20
55

+
-

+
NT
NT

512
1,024

-

-/NT
-/-

/
NT
-/-

_
NT

-

-/+-/-

3

4

NOTE. HGE = humangranulocyticehrlichiosis;IFA = indirectimmunofluorescence
assay;NT = not tested;TBEV = tick-borneencephalitisvirus; + =
positive; - = negative.
* With use of GE9f and GElOrprimersspecificto the HGE agent andgroESLnestedprimers.
t Reciprocalvalue of serumdilution.
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ing titerof antibodyto E. chaffeensisantigen.Patient1 developed only IgM antibodiesto B. burgdorferisensu lato.
PCRanalysiswithprimersGE9fandGElOrgeneratedproducts of the predictedmolecularsize (919 bp) from DNA extractedfrom blood samples from three of four patientsthat
were obtainedat their firsthospitalvisit. Similarresultswere
obtainedwith PCR analysis with the groESLprimers(table
3). Amplificationproductswere not obtainedwhen material
collectedduringthe follow-upperiodwas subjectedto the same
PCRassay.No productwas observedat anytimewhenprimers
specific to E. chaffeensiswere used.
The nucleotidesequenceof the 16S rRNA gene amplicon
from the agent identifiedin patient 1 was reported[11] to be
identicalto the originalsequenceof DNA fromthe HGEagent
[1]. Two regions of the groESLoperon were amplifiedand
sequencedfromDNA extractedfromblood samplesfrompatients 1, 2, and 4. The nucleotidesequencesof DNA fromthe
HGE agents identifiedin all three patientswere identicalto
one anotherandto previouslyreportedsequencesof DNA from
the HGEagentthatwere fromthe regionof thegroESLoperon
amplifiedwith primersHS43 and HS45 [16]. Sequenceswere
found to be more variablein the region amplifiedby primers
HSVF and HSVR in a previouscomparison,and there were
five nucleotidepositionsin whichthe sequencesof DNA from
North Americanand EuropeanHGE agents consistentlydiffered[ 16]. The sequencesof DNA fromthe HGEagentsidentified in all threeSlovenianpatientswereidenticalin thisvariable
regionandweremost similarto sequencespreviouslyamplified
from DNA from E. phagocytophila,includingsequences of
PCR productsfrom DNA from E. phagocytophilanaturally
infectinga Swiss horse(100%similarity)andfromDNA from
E. phagocytophilaexperimentallyinfectinga goat (99.4%)and
sheep (99.5%)[16].
The sequencesof DNA from the HGE agents identifiedin
the Slovenianpatientsmatchedthe sequencesof DNA from
EuropeanHGEagentsin the five positionsin which consistent
differenceswere previouslydetected.A 99.2% similarityto
sequencesof DNA fromNorthAmericanHGEagents,including those identifiedin two patients,a tick, and a horse, was
found. Finally, a 1,256-bpregion was amplifiedfrom DNA
from the HGE agent identifiedin patient2 by using primers
HS43 and HSVR. This sequencewas depositedin GenBank
(Bethesda,MD; accessionnumberAF033101). The sequence
of this longerproductdifferedfromthatof the DNA fromthe
HGE agent identifiedin the Swiss horse by one nucleotide
(99.9% similarity).Sequencevariationat the nucleotidelevel
did not changethe predictedaminoacid sequencefor the portion of the groEL gene included in the PCR products.The
predictedaminoacid sequenceswere identicalfor all of these
sequences.
Discussion
To ourknowledge,this is the firstseriesof Europeanpatients
with acute HGE to be described.Each patienthad receiveda
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tick bite while in centralSlovenia,andnone had traveledoutside of Sloveniaduringthe indicatedincubationperiod.In this
region, tick-bore encephalitisand Lyme borreliosisare also
endemic,andetiologicagentsof bothinfectionsaretransmitted
by I. ricinus [12, 13]. This species is also knownas the vector
of tick-bornefever due to E. phagocytophilain ruminantsin
Europe [17]. Because I. ricinus is the most widespreadtick
speciesin thispartof Europe,it appearslikelythatit is a vector
of the HGE agent in Europe.
The clinical featuresof and laboratoryparametersfor our
fourpatientswere similarto those reportedin cases fromthe
United States[18-20]. However,the severityof the illness in
Sloveniawas mildto moderaterelativeto HGEin somepatients
in the UnitedStates,where deathswere reportedin two of 41
cases [19]. In general, all laboratoryabnormalitieswere of
short durationand had resolved by 14 days after the initial
presentation.Symptomsabatedwithoutthe use of antibiotics
in two patients,and the only patientto receive doxycycline,
the drugof choice for therapyfor HGE [21], was treatedafter
defervescence.None of the patients died, and no long-term
consequenceswere foundduringa follow-upof 1 year.
In our study, acute infectionwith the HGE agent in three
patientswas confirmedby PCR analysis early in the course
of illness when IgG antibodycould not be detected. Other
researcherswho used the same primers,detected ehrlichial
DNA in 43% of acute-phaseblood samples[19]. Serologyfor
IgG was useful for the retrospectiveconfirmationof infection.
Patient1 could have been coinfectedwith B. burgdorferi,althoughno clinicalsignscompatiblewithearlyLymeborreliosis
werepresent.Cross-reactiveantibodiesto B. burgdorfericould
have resultedfrominfectionwith the HGEagentas described
previously[22]. The findingsof a standingtiterof antibodyto
E. chaffeensisin one patientand seroconversionto E. chaffeensis in anotherpatientareof potentialinterest,althoughdual
reactivityto E. chaffeensisantigenshas been shown in 8% to
17%of HGEcases in the UnitedStates[19, 20]. Thepossibility
of additionalEhrlichiaspeciescausinghumanillnessin Europe
has not been ruledout.
PCR assays targetingthe 16S rRNAgene have been useful
in detectingehrlichialinfectionsin humans.The E. phagocytophila genogroup,as defined by the similaritiesamong sequences of the 16S rRNA gene [1], containsseveral closely
relatedandpossiblyconspecifictaxa.In previousreports,only
three base positions within the 1,433-bpamplifiedregion of
the 16S rRNAgene alloweddifferentiation
of thesepreviously
identifiedspecies. Thus, we chose to amplify and sequence
portionsof the groESLheatshockoperonto provideadditional
resolution.A 395-bpregionof the groELgene frommembers
of the E. phagocytophilagenogrouphas been shownto contain
a distinctpatternof bases in severalpositionsthathas consistently (to date) separatedthe sequencesinto Old World and
New Worldgroupings[16]. In this study,nucleotidesequences
forthis variableregionfromDNA fromthe HGEagentsidentified in three of our patientswere identicalto each other and
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were similarto other sequencesclusteringin the Old World
group.
This initialstudyshouldpromptcliniciansand practitioners
to be awareof the potentialfor ehrlichialinfectionin febrile
patientsin Europe.In most of Europe,the main differential
diagnosisof HGE would be a viral infection,particularlythe
initial phase of tick-bore encephalitis(which has a similar
clinicalpresentationandis usuallyaccompaniedby leukopenia,
and,in somepatients,elevatedliverenzyme
thrombocytopenia,
levels [23]).
Althoughthe clinical and laboratoryfindingsin this small
series of patientsmay not representthe completespectrumof
disease,our findingsindisputablydemonstratethe presenceof
HGEin Slovenia.HGEshouldbe now includedin the differential diagnosisof febrileillnesses in Europeanpatientspresenting duringthe monthswhen tick bites occur.
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